Table 3.
Floxed allele | Gene product description | Process under investigation | Phenotype/process affected | Reference |
---|---|---|---|---|
Zbtb7a | Transcription factor: Zinc finger and BTB domain containing 7A | Hematopoietic Stem Cell (HSC) maintenance | Embryonic lethal, anemia | [52] |
Myc | Transcription factor: Myc proto-oncogene protein | Primitive Hematopoiesis | Embryonic lethal, blocks HSC differentiation, absence of primitive erythrocytes | [53] |
SCL/Tal-1 | Transcription factor | Hematopoietic Stem Cells | Embryonic lethal, genesis of HSCs, differentiation into erythroid and megakaryocytic progenitors, anemia, thrombocytopenia | [54] |
Asxl1 (also Asxl1: nlacZ/nGFP knock-in) | Transcription factor: Additional sex combs like transcriptional regulator 1 | Erythropoiesis | Embryonic lethal, myelodysplastic syndrome | [55] |
Meis1 | Transcription factor: Homeobox protein Meis1 | Erythropoiesis | Primitive hematopoietic repopulating cells and megakaryocytic/erythroid progenitor expansion, abnormal HSC function | [56] |
Klf1 | Transcription factor: Krüppel-like factor 1 | Hemoglobin Switching | Embryonic lethal, β-like globin gene expression, anemia | [57] |
Klf2 | Transcription factor: Krüppel-like factor 2 | Hemoglobin Switching | Embryonic lethal, β-like globin gene expression, anemia | [57] |
Bcl1 1a | Transcription factor: C2H2 type zinc-finger | Hemoglobin Switching | γ-globin (HbF) repression | [58] |
Mi2/β | Chromodomain helicase DNA binding protein 4 | Hemoglobin Switching | γ-globin (HbF) repression | [59] |
Atg7 | Interacting protein: Ubiquitin - activating enzyme E1-like protein | Erythropoiesis | Mitochondrial autophagy, splenomegaly, death via severe anemia | [60] |
Med1 | Mediator complex subunit 1: required for SP1 activation as part of CRSP complex | Erythropoiesis | Block in erythroid development | [61] |
Taf10 | Interacting protein: TATA-box binding protein associated factor 10 | Erythropoiesis | Embryonic lethal | [62] |
Gfi 1b | Transcription factor: Growth factor independent 1 B transcription repressor | Erythropoiesis | Abnormal HSC function | [63] |
Tsc 1/Rptor | Interacting protein: Tuberous sclerosis 1 interacting protein/regulatory associated protein of mTOR complex 1 | Erythropoiesis | Role of mTORC1 in erythropoiesis, increased neonatal mortality, macrocytic/microcytic anemia | [64] |
Ldb1 | Interacting protein: LIM domain binding 1 | Erythropoiesis | Embryonic lethal, abnormal erythroid gene expression, defective primitive erythropoiesis, continuously required for definitive erythropoiesis and megakaryopoiesis | [65] |
Pit1 | Interacting protein: Solute carrier family 20 (phosphate transporter) member 1 | Erythropoiesis | Erythroid maturation, anemia, myelodysplastic syndromes | [66] |
Sf3b1K700E knock-in |
Interacting protein: Splicing factor 3b subunit 1 | Erythropoiesis | Impaired erythropoiesis and aberrant splicing, myelodysplastic syndromes | [67] |
Miz-1 | Transcription factor: Myc-interacting zinc finger protein 1 | Erythropoiesis | Embryonic lethal, required for embryonic and stress-induced erythropoiesis, perturbed erythroid differentiation and development, severe anemia | [68] |
Brg1 | Transcription factor: Brahma-related gene 1 | Erythropoiesis, Vascular Development | Embryonic lethal, altered globin expression, anemia, erythropoietic/vascular abnormalities | [69] |
RhoA | Hub protein: Ras homolog family member A | Erythropoiesis | Embryonic lethal, cytokinesis in erythroblasts, failed definitive erythropoiesis, anemia | [70] |
Spry1 | Interacting protein: Sprouty RTK signaling antagonist 1 | Erythropoiesis | Perturbed erythroid development, reticulocytosis, heightened splenic erythropoiesis, regulator of erythropoiesis during anemia, transducer of EPOR signals, and candidate suppressor of Jak2 activity | [71] |
Vegf | Growth factor: Vascular endothelial growth factor | Erythropoiesis | Erythropoietic lineage development, increased Gatal levels, increased erythroid differentiation | [72] |
Stat5 | Transcription factor: Signal transducer and activator of transcription 5A | Erythropoiesis | Reduced transferrin receptor gene expression, microcytic, hypochromic anemia | [73] |
cdc42 | Rho GTPase Cdc42: Cell division control protein 42 homolog | Erythropoiesis | Balance between myelopoiesis and erythropoiesis, altered gene expression, fatal myeloproliferative disorder, anemia, splenomegaly | [74] |
Tfr2 | Membrane protein: Transferrin receptor 2 | Iron Metabolism | Liver iron overload, inadequate hepcidin levels, iron-deficient anemia | [75] |
Mfrn1 | Mitochondrial iron transporter: Mitoferrin-1 | Iron Metabolism | Embryonic lethal, reduced erythroblast formation, severe anemia | [76] |
Piga | Enzyme: Phosphatidylinositol glycan anchor biosynthesis class A | Erythropoiesis | Embryonic lethal, paroxysmal nocturnal hemoglobinuria (PNH) | [45] |
Jak2V617F knock-in | Non-receptor tyrosine kinase: Janus kinase 2(JAK2) | Erythropoiesis | Polycythemia-like disease (all major features of human polycythemia vera) | [77] |
Phd1, Phd2, Phd3 |
Enzyme: Prolyl hydroxylase domain protein 1, 2, or 3 (3 PHD isoforms) | Erythropoiesis | Erythrocytosis | [78] |
Epo | Growth factor: Erythropoietin (EPO) | Erythropoiesis | Embryonic lethal, chronic, normocytic, normochromic anemia, pre-clinical model for anemia of Epo deficiency | [79] |
pRb | Tumor suppressor protein: Retinoblastoma protein | Erythropoiesis | Defects in cell cycle regulation and mitochondrial function, anemia, myelodysplastic syndromes | [80] |
Trim33 | Transcriptional corepressor: Tripartite motif-containing 33, also known as transcriptional intermediary factor 1 gamma (TIF1-γ) | Erythropoiesis | Embryonic lethal | [81] |
Bcl-x | Anti-apoptotic factor: Bcl-2-like protein 1 | Erythropoiesis | Required for the survival of erythroid cells at the end of maturation, which includes enucleated reticulocytes in circulation, hemolytic anemia, hyperplasia of immature erythroid cells, splenomegaly | [82] |
Nix | Pro-apoptotic factor: BH3-only-like protein | Erythropoiesis | Reticulocytosis, thrombocytosis, splenomegaly, splenic and bone marrow erythroblastosis, reduced apoptosis during erythrocyte maturation | [83] |
Tr2/Tr4 | Transcription factor: Testicular receptor 2 (TR2), Testicular receptor 4 (TR4) | Hemoglobin Switching | Embryonic lethal, γ-globin gene repression | [84] |
Zbp-89 (Zfp148) | Transcription factor: Zinc finger protein 148 | Hematopoiesis | Stress erythropoiesis, erythroid lineage development, anemia, thrombocytopenia, myeloid and B lymphoid lineage anomalies, altered HSC gene expression | [85] |
Trim28 | Transcriptional cofactor: Tripartite motif-containing protein 28, also known as transcriptional intermediary factor 1 beta (TIF1β) | Erythropoiesis | Cell- autonomous development of immature erythroblasts in bone marrow, essential for erythroblasts differentiation, anemia, increased apoptosis, reduced erythroid transcription factor expression, reduced heme biosynthesis | [86] |
Ccbel | Lymphangiogenic factor: Collagen and calcium-binding epidermal growth factor domain-containing protein 1 | Primitive Erythropoiesis | Secreted lymphangiogenic CCBE1 is essential for fetal, but not postnatal erythropoiesis, loss of CCBE1 signaling impairs erythroblastic island formation and function, not required in hematopoietic cells, severe anemia, increased apoptosis | [87] |
Sur | Inhibitor of apoptosis: Survivin | Erythropoiesis | Essential for steady-state hematopoiesis and survival of adult, high level expression critical for proper erythroid differentiation, bone marrow depletion, pancytopenia, erythrocyte abnormalities, hypocellular spleen, hematopoietic cell death | [88] |
Runxl | Transcription factor: Runt-related transcription factor 1 | Hematopoiesis | Embryonic lethal, not required in adult hematopoietic compartment, abnormal HSCs, defective T- and B-cell maturation, inefficient platelet production, mild myeloproliferative phenotype | [89] |
α4 | Transmembrane receptor: α4 integrin subunit | Hematopoietic Stem Cells | Progenitor cell influx into the peripheral blood, delayed erythroid and myeloid regeneration, hematopoietic abnormalities | [90] |
Raf-1 | Enzyme: RAF proto-oncogene serine/threonine-protein kinase | Erythropoiesis | Embryonic lethal, anemia, accelerated erythroid differentiation | [91] |
Jak2 | Non-receptor tyrosine kinase: Janus kinase 2 | Hematopoiesis | Embryonic lethal, impaired hematopoiesis, splenic atrophy, severely diminished erythropoiesis and thrombopoiesis, modestly affected granulopoiesis and monocytopoiesis | [92] |
Abcb7 | Mitochondrial ATP-binding cassette sub-family B member 7 | Hematopoiesis | X-linked sideroblastic anemia with ataxia (XLSA/A) due to inhibition of heme biosynthesis, damaged mitochondria, pancytopenia, hypocellular bone marrow | [93] |
Ufbp1 | Inhibitor of apoptosis in ER-stressed cells: Ufm1 binding protein 1 | Hematopoiesis | Embryonic lethal, impaired hematopoiesis, defective erythroid development, pancytopenia, suppressed GATA-1 and KLF1 expression | [94] |
Ezh2 | Enzymatic component of Polycomb Repressive Complex 2: Enhancer of zeste homolog 2 | Hematopoietic Stem Cells | Embryonic lethal, essential for fetal liver, but not bone marrow erythropoiesis, defective HSC expansion, compromised lymphopoiesis, reduced H3K27me3 levels suggesting epigenetic status of HSCs is developmentally regulated, anemia | [95] |
Rcor1 | Transcriptional corepressor: REST (repressor element-1 silencing transcription factor) corepressor 1 | Hematopoietic Stem Cells | Embryonic lethal, promotes erythropoiesis by repressing HSC and/or progenitor genes, as well as genes and signaling pathways that lead to myeloid cell fate, block in fetal erythropoiesis at the proerythroblast stage, anemia | [96] |
Setd8 | Histone Methyltransferase: monomethylates histone H4 lysine 20 (H4K20mel) | Erythropoiesis | Embryonic lethal, defect in primitive erythropoiesis, abnormalities in cell cycle progression, regulates erythroid maturation, represses Gata2 expression, severe anemia | [97] |
Smad4 | Signal transduction: Mothers against decapentaplegic homolog 4 |
Erythropoiesis | Not required for adult erythropoiesis, severe anemia due solely to blood loss, iron deficiency | [98] |
Ulk1 | Enzyme: Serine/threonine-protein kinase | Erythropoiesis | Autophagy machinery that leads to the elimination of organelles in erythroid cells | [99] |
Ck2β | Enzyme: serine-threonine kinase composed of two catalytic (α) and two regulatory (β) subunits | Hematopoiesis | Embryonic lethal, regulates definitive hematopoiesis of all hematopoietic cell lineages | [100] |
Flvcr1a | Heme exporter membrane protein: Feline leukemia virus subgroup C receptor 1 | Erythropoiesis | Embryonic lethal, heme export control, severe macrocytic anemia, splenomegaly, iron accumulation in duodenum, liver and spleen, reduced BFU-E and CFU-E, defective erythroid differentiation | [101] |
Rhau | RNA helicase: RNA helicase associated with AU-rich element | Hematopoiesis | Embryonic lethal, hemolytic anemia, differentiation defect at the proerythroblast stage | [102] |
Add3 | Adducins: Skeletal protein involved in the assembly of spectrin-actin network | RBC membrane skeleton structure | Animals were viable and presented no obvious erythroid cell defects | [103] |
cyclin ET74A T393A knock-in | Cell cycle regulator: Complexes with the CDK2 cyclin-dependent kinase subunit | Erythropoiesis | Links ubiquitin-proteasome pathway control of G1-to-S-phase progression to regulation of metabolism and gene expression in terminally differentiating bone marrow erythroid cells, abnormal erythropoiesis characterized by a large expansion of abnormally proliferating progenitors, impaired differentiation, dysplasia, and anemia, models early stage human refractory anemia/myelodysplastic syndrome | [104] |
Rps14 | 40S ribosomal subunit protein S14 | Erythropoiesis | Erythroid differentiation defect dependent on p53 characterized by apoptosis during transition from polychromatic to orthochromatic erythroblasts, age-dependent progressive anemia, megakaryocyte dysplasia, block in erythroid differentiation, loss of HSC quiescence | [105] |
Rps6 | 40s Ribosomal subunit protein S6 | Erythropoiesis | Hypoproliferative macrocytic anemia, granulocytopenia, thrombocytosis, lymphopenia (model for Diamond-Blackfan Anemia and myelodysplastic syndrome) | [106] |
Ppp2ca | Enzyme: Serine/threonine phosphatase, protein phosphatase 2A | Erythropoiesis | Perturbed definitive erythropoiesis characterized by fetal liver atrophy, reduced Terll9+ cell number, atypical expression patterns of molecular markers, reduced colony formation, reduction in definitive globin gene expression | [107] |
Dicer | Enzyme: Endoribonuclease | Hematopoietic Stem Cells | Down-regulation of erythroid genes, defective erythroid linage differentiation | [108] |
Ml1 | Enzyme: Mixed-lineage leukemia | Hematopoietic Stem Cells | Embryonic lethal, reduced numbers of HSCs, abnormal HSC function | [109] |
Ufm1 | Ubiquitin-like modification system: Ubiquitin-fold modifier 1 | Hematopoietic Stem Cells | Embryonic lethal, diminished hematopoietic development, increased HSC death, severe anemia, cytopenia, elevated endoplasmic reticulum stress, blocked autophagic degradation, increased ROS | [110] |
Rac1, Rac2 | Rac GTPases: Racl and Rac2 regulates many aspects of intracellular actin dynamics | Erythropoiesis | Abnormal BFU-E and CFU-E morphology, decreased megakaryocyte-erythrocyte progenitors in bone marrow, increased splenic erythropoiesis | [111] |
Adar1 | RNA-editing enzyme: Adenosine deaminase acting on RNA 1 | Hematopoietic Stem Cells | Embryonic lethal, abnormal HSC function, increased HSC apoptosis | [112] |
Sod2 | Enzyme: Superoxide dismutase 2 | Hematopoietic Stem Cells | Increased ROS in erythroid progeny, diminished erythrocytes, decreased ferrochelatase activity, extramedullary hematopoiesis, systemic iron redistribution, abnormal gene expression (hematopoietic transcription factors, globins, and iron-response genes), changes in histone posttranslational modification | [113] |